Items per page
1 - 69 of 69
Title Published in Access level OA Policy Year Views Downloads
Interleukin‐18 Binding Protein (IL‐18BP) Deficiency Affects Lymphocyte Activation and IL‐18 Expression in a Mouse Model of Liver InflammationEuropean Journal of Immunology
accessLevelPublic
2025 100 85
Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptorsCell communication and signaling
accessLevelPublic
2025 89 37
Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in miceFrontiers in immunology
accessLevelPublic
2024 130 38
Oxidation-sensitive cysteines drive IL-38 amyloid formationCell reports
accessLevelPublic
2024 123 29
GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer modelFrontiers in immunology
accessLevelPublic
2024 175 49
Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritisFrontiers in immunology
accessLevelPublic
2023 181 164
Editorial : Modulating cytokines as treatment for autoimmune diseases and cancer : volume IIFrontiers in immunology
accessLevelPublic
2023 93 171
IL-18 Binding Protein–Producing Cells Attenuate Anemia in Murine Macrophage Activation SyndromeThe Journal of immunology
accessLevelPublic
2023 118 102
Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody ProductionInternational journal of molecular sciences
accessLevelPublic
2023 121 107
Special Issue “IL-1 family cytokines in host defense, inflammation and cancer”Cytokine
accessLevelPublic
2022 206 189
Arithmétique de la malbouffeRevue médicale suisse
accessLevelPublic
2022 199 343
Editorial: Post-translational modifications of extracellular signaling molecules and antigens in immune and inflammatory responsesFrontiers in immunology
accessLevelPublic
2022 176 75
IL ‐38 orchestrates proliferation and differentiation in human keratinocytesExperimental dermatology
accessLevelPublic
2022 267 181
Epigenetic remodeling of downstream enhancer regions is linked to selective expression of the IL1F10 gene in differentiated human keratinocytesGene
accessLevelPublic
2022 282 150
Multifaceted roles of IL-38 in inflammation and cancerCytokine
accessLevelPublic
2022 264 180
Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticlesJournal of controlled release
accessLevelPublic
2022 388 337
IL-1 family antagonists in mouse and human skin inflammationFrontiers in Immunology
accessLevelPublic
2021 367 151
Un équilibre à fleur de peauRevue médicale suisse
accessLevelPublic
2021 248 134
IL-38 Ablation Reduces Local Inflammation and Disease Severity in Experimental Autoimmune EncephalomyelitisJournal of Immunology
accessLevelPrivate
2021 293 0
Intracellular IL-1 receptor antagonist isoform 1 released from keratinocytes upon cell death acts as an inhibitor for the alarmin IL-1αJournal of Immunology
accessLevelRestricted
2020 358 2
Interleukin-33 Signaling Controls the Development of Iron-Recycling MacrophagesImmunity
accessLevelPublic
2020 469 215
Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation SyndromeJournal of Immunology
accessLevelRestricted
2020 282 1
Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the diseaseRheumatology
accessLevelRestricted
2020 321 8
Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytesPLOS ONE
accessLevelPublic
2019 380 189
Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in miceBlood
accessLevelRestricted
2018 460 2
The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expressionPLOS ONE
accessLevelPublic
2018 512 247
IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitroAnnals of the Rheumatic Diseases
accessLevelRestricted
2017 434 0
Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory ResponsesJournal of Immunology
accessLevelRestricted
2017 759 2
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's diseaseClinical and experimental immunology
accessLevelRestricted
2016 544 2
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokinesCytokine
accessLevelRestricted
2016 524 1
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid CellsJournal of Immunology
accessLevelRestricted
2016 546 2
Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to PeriodontitisPLOS ONE
accessLevelPublic
2016 463 191
The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseasesCytokine
accessLevelRestricted
2015 322 0
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial InfectionPloS one
accessLevelPublic
2015 558 211
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signalingImmunity, inflammation and disease
accessLevelPublic
2015 1,188 188
Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 MiceThe Journal of immunology
accessLevelRestricted
2015 675 2
Immune-mediated experimental arthritis in IL-33 deficient miceCytokine
accessLevelRestricted
2014 671 0
The severity of experimental arthritis is independent of IL-36 receptor signalingArthritis research & therapy
accessLevelPublic
2013 628 239
Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditionsJournal of leukocyte biology
accessLevelPublic
2013 546 524
Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis"Joint bone spine
accessLevelRestricted
2013 567 0
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiencyArthritis research & therapy
accessLevelPublic
2013 642 262
Endogenous IL-1α is a chromatin-associated protein in mouse macrophagesCytokine
accessLevelRestricted
2013 630 1
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritisJoint bone spine
accessLevelPublic
2012 746 767
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitisEuropean Journal of Immunology
accessLevelRestricted
2012 619 3
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promotersJournal of leukocyte biology
accessLevelPrivate
2012 707 0
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cellsBlood
accessLevelPublic
2012 873 995
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in miceAnnals of the rheumatic diseases
accessLevelRestricted
2012 670 0
Inhibition of osteoclast differentiation by the interleukin (IL)-1 family cytokine IL-33IBMS boneKEy
accessLevelPublic
2011 629 737
IL-36R ligands are potent regulators of dendritic and T cellsBlood
accessLevelRestricted
2011 657 0
IL-33 biology with potential insights into human diseasesNature reviews. Rheumatology
accessLevelRestricted
2011 607 0
IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodelingCytokine
accessLevelPublic
2011 627 979
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritisArthritis and rheumatism
accessLevelRestricted
2011 643 0
Expression and function of the NALP3 inflammasome in rheumatoid synoviumImmunology
accessLevelRestricted
2010 558 0
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in miceThe Journal of immunology
accessLevelRestricted
2010 558 0
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonistArthritis and rheumatism
accessLevelRestricted
2010 613 0
IL-1 pathways in inflammation and human diseasesNature reviews. Rheumatology
accessLevelRestricted
2010 734 1
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritisArthritis and rheumatism
accessLevelRestricted
2009 654 0
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in miceArthritis research & therapy
accessLevelPublic
2009 799 808
Mutations in the IL1RN locus lead to autoinflammationNature reviews. Rheumatology
accessLevelRestricted
2009 577 0
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failureJoint bone spine
accessLevelRestricted
2009 566 0
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memoryThe Journal of immunology
accessLevelRestricted
2009 867 0
Interleukin-33 is biologically active independently of caspase-1 cleavageThe Journal of biological chemistry
accessLevelPublic
2009 673 497
IL-1, IL-18, and IL-33 families of cytokinesImmunological reviews
accessLevelPublic
2008 903 3,684
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33Cytokine
accessLevelRestricted
2008 710 0
Expression and function of junctional adhesion molecule-C in human and experimental arthritisArthritis research & therapy
accessLevelPublic
2007 644 335
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cellsCytokine
accessLevelRestricted
2007 520 0
Leukocyte migration to rheumatoid joints: Enzymes take overArthritis and rheumatism
accessLevelRestricted
2006 591 1
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytesArthritis research & therapy
accessLevelPublic
2006 580 284
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient miceArthritis research & therapy
accessLevelPublic
2004 481 165
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack